Randomized, Blinded, Placebo-Controlled Trial of High Dose Methotrexate With Leucovorin Rescue (HDMTX-LV) With or Without Glucarpidase in Osteosarcoma
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
successful advancement to the next cycle of chemotherapy at scheduled time
one week
No
Pete Anderson, MD, PhD
Principal Investigator
M.D. Anderson Cancer Center
United States: Food and Drug Administration
PR001-CLN-pro012
NCT00634322
October 2008
April 2009
Name | Location |
---|